https://www.jpost.com/health-and-wellness/article-744695
0
0
5/31/23 at 8:59am
Organization
The Jerusalem Post
Author
By JUDY SIEGEL-ITZKOVICH
Since anti-PD1 is the leading immunotherapy treatment in cancer patients, such an achievement can impact the quality of life of thousands of cancer patients worldwide every day.
Create an account
or login to join the discussion